Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L von Moltke

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Journal of Clinical Pharmacology|November 8, 2001
Human drug metabolism and the cytochromes P450: application and relevance of in vitro modelsK Venkatakrishnan, L L Von Moltke, D J Greenblatt
Journal of Clinical Pharmacology|June 4, 1999
Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugsK Venkatakrishnan, L L von Moltke, D J Greenblatt
Journal of Pharmaceutical Sciences|April 3, 1999
Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activityK Venkatakrishnan, L L von Moltke, D J Greenblatt
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrateK Venkatakrishnan, L L von Moltke, D J Greenblatt
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolismE Störmer, L L von Moltke, D J Greenblatt
Journal of Pharmaceutical Sciences|July 2, 1998
Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approachK Venkatakrishnan, L L von Moltke, D J Greenblatt
Clinical Pharmacokinetics|March 10, 2000
Effects of the antifungal agents on oxidative drug metabolism: clinical relevanceK Venkatakrishnan, L L von Moltke, D J Greenblatt
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 27, 2004
Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in ratsM D Perloff, L L von Moltke, D J Greenblatt
Clinical Pharmacokinetics|February 1, 1993
Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implicationsL L von Moltke, D J Greenblatt, R I Shader
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 15, 2003
Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expressionM D Perloff, L L Von Moltke, D J Greenblatt
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Pharmacology|November 8, 2001
Human drug metabolism and the cytochromes P450: application and relevance of in vitro modelsK Venkatakrishnan, L L Von Moltke, D J Greenblatt
Journal of Clinical Pharmacology|June 4, 1999
Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugsK Venkatakrishnan, L L von Moltke, D J Greenblatt
Journal of Pharmaceutical Sciences|April 3, 1999
Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activityK Venkatakrishnan, L L von Moltke, D J Greenblatt
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrateK Venkatakrishnan, L L von Moltke, D J Greenblatt
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolismE Störmer, L L von Moltke, D J Greenblatt
Journal of Pharmaceutical Sciences|July 2, 1998
Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approachK Venkatakrishnan, L L von Moltke, D J Greenblatt
Clinical Pharmacokinetics|March 10, 2000
Effects of the antifungal agents on oxidative drug metabolism: clinical relevanceK Venkatakrishnan, L L von Moltke, D J Greenblatt
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 27, 2004
Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in ratsM D Perloff, L L von Moltke, D J Greenblatt
Clinical Pharmacokinetics|February 1, 1993
Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implicationsL L von Moltke, D J Greenblatt, R I Shader
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 15, 2003
Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expressionM D Perloff, L L Von Moltke, D J Greenblatt
Pageof 9